Quest Diagnostics Incorporated (DGX) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States.
Total Assets Chart for Quest Diagnostics Incorporated
Quest Diagnostics Incorporated (DGX) total assets for FY2025 were USD 16.2B, a 0.4% change from FY2024. Quest Diagnostics Incorporated's total assets grew from USD 1.4B in 1996 to USD 16.2B in 2025 (1063.0% over 29 years). Total assets compound annual growth rate: 5-year CAGR of 3.0%, 10-year CAGR of 5.0%, 20-year CAGR of 5.7%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $26.32B
- Implied Share Price
- $238.50
- Enterprise Value
- $31.55B
- Revenue (TTM)
- $11.56B
- EBITDA
- $2.27B
- Profit Margin
- 9.19%
- Trailing P/E
- 25.35
- Forward P/E
- 20.96
- Price/Book (MRQ)
- 3.43
- Price/Sales (TTM)
- 2.28
- EV/EBITDA
- 14.01
- EV/Revenue
- 2.73
- Dividend Yield
- 1.41%
- Book Value
- $68.33
- Free Cash Flow (FY2025)
- $1.36B
- Free Cash Flow Yield
- 5.16%
Snapshot as of 6th August 2026 — not point-in-time controlled, may lag the live market by a few days.